Zentalis Pharmaceuticals Llc (ZNTL) Insider Trading
- $126,584,246.00
- $93,729,614.81
- May 9, 2024
- Cam Gallagher
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 9, 2024 | Insider | 3,356 | $12.62 | Sell | $42,352.72 | |
| Feb. 12, 2024 | President | 1,173 | $11.44 | Sell | $13,419.12 | |
| Feb. 12, 2024 | CFO | 2,573 | $11.44 | Sell | $29,435.12 | |
| Nov. 13, 2023 | CEO | 5,000 | $10.29 | Buy | $51,450.00 | |
| Nov. 10, 2023 | Director | 17,000 | $9.88 | Buy | $167,960.00 | |
| Oct. 4, 2023 | CFO | 5,482 | $19.50 | Sell | $106,899.00 | |
| Oct. 4, 2023 | Insider | 10,628 | $19.50 | Sell | $207,246.00 | |
| Sept. 11, 2023 | Director | 5,000 | $25.05 | Sell | $125,250.00 | |
| June 20, 2023 | Major Shareholder | 4,760,000 | $22.66 | Buy | $107,861,600.00 | |
| May 31, 2023 | President | 27,768 | $26.27 | Sell | $729,465.36 | |
| May 26, 2023 | Insider | 80,000 | $30.02 | Sell | $2,401,600.00 | |
| Feb. 13, 2023 | CFO | 2,624 | $20.42 | Sell | $53,582.08 | |
| Feb. 13, 2023 | President | 3,332 | $20.42 | Sell | $68,039.44 | |
| Feb. 13, 2023 | Insider | 3,807 | $20.42 | Sell | $77,738.94 | |
| Feb. 6, 2023 | President | 10,000 | $22.27 | Sell | $222,700.00 | |
| Jan. 17, 2023 | President | 10,000 | $24.15 | Sell | $241,500.00 | |
| Jan. 5, 2023 | President | 10,000 | $21.02 | Sell | $210,200.00 | |
| Nov. 15, 2022 | President | 12,500 | $22.77 | Sell | $284,625.00 | |
| Nov. 7, 2022 | President | 12,500 | $23.67 | Sell | $295,875.00 | |
| Oct. 17, 2022 | President | 12,500 | $23.51 | Sell | $293,875.00 | |
| Oct. 5, 2022 | President | 12,500 | $22.32 | Sell | $279,000.00 | |
| Sept. 15, 2022 | President | 12,500 | $25.26 | Sell | $315,750.00 | |
| July 20, 2022 | COO | 5,000 | $30.00 | Sell | $150,000.00 | |
| July 14, 2022 | Chief Operating Officer | 3,290 | $30.01 | Sell | $98,732.90 | |
| July 13, 2022 | Chief Operating Officer | 1,710 | $30.02 | Sell | $51,334.20 | |
| July 13, 2022 | COO | 1,710 | $30.02 | Sell | $51,334.20 | |
| July 5, 2022 | COO | 25,000 | $30.07 | Sell | $751,750.00 | |
| April 11, 2022 | COO | 5,000 | $30.55 | Sell | $152,750.00 | |
| April 5, 2022 | Director | 10,000 | $50.48 | Sell | $504,800.00 | |
| April 4, 2022 | CFO | 17,080 | $50.09 | Sell | $855,537.20 | |
| April 4, 2022 | CEO | 10,471 | $48.50 | Sell | $507,843.50 | |
| March 21, 2022 | COO | 10,000 | $49.07 | Sell | $490,700.00 | |
| March 15, 2022 | Director | 10,000 | $41.92 | Sell | $419,200.00 | |
| March 10, 2022 | COO | 10,000 | $46.94 | Sell | $469,400.00 | |
| March 7, 2022 | Director | 10,000 | $44.94 | Sell | $449,400.00 | |
| March 1, 2022 | CEO | 10,471 | $49.79 | Sell | $521,351.09 | |
| Feb. 23, 2022 | CFO | 1,913 | $49.10 | Sell | $93,928.30 | |
| Feb. 22, 2022 | COO | 10,000 | $49.09 | Sell | $490,900.00 | |
| Feb. 14, 2022 | SVP | 601 | $50.23 | Sell | $30,188.23 | |
| Feb. 14, 2022 | Director | 7,188 | $50.19 | Sell | $360,765.72 | |
| Feb. 14, 2022 | CEO | 4,733 | $50.23 | Sell | $237,738.59 | |
| Feb. 14, 2022 | COO | 4,688 | $50.26 | Sell | $235,618.88 | |
| Feb. 14, 2022 | Insider | 691 | $50.23 | Sell | $34,708.93 | |
| Feb. 10, 2022 | COO | 10,000 | $53.50 | Sell | $535,000.00 | |
| Feb. 7, 2022 | Director | 10,000 | $53.45 | Sell | $534,500.00 | |
| Feb. 1, 2022 | CEO | 10,471 | $57.58 | Sell | $602,920.18 | |
| Jan. 20, 2022 | SVP | 10,000 | $60.63 | Sell | $606,300.00 | |
| Jan. 18, 2022 | Director | 10,000 | $62.64 | Sell | $626,400.00 | |
| Jan. 10, 2022 | COO | 10,000 | $68.41 | Sell | $684,100.00 | |
| Jan. 5, 2022 | Director | 10,000 | $75.49 | Sell | $754,900.00 |
Insiders are both buying and selling Zentalis Pharmaceuticals Llc stock.
The insider traders at Zentalis Pharmaceuticals Llc are: Cam Gallagher, Kevin D Bunker, Anthony Y Sun, Melissa B Epperly, David Michael Johnson, Kimberly Blackwell, Kevin D. Bunker, Dimitris Voliotis, Bunker Kevin D., Alexis Pinto, Global Investors Lp Viking, Jan Skvarka, Diana Hausman, Matrix Capital Management Comp, and Carrie Brownstein
The most active insider trader at Zentalis Pharmaceuticals Llc is Cam Gallagher with 33 trades.
Global Investors Lp Viking has sold the most Zentalis Pharmaceuticals Llc stock with a total value of $50,500,000.00.
Matrix Capital Management Comp has bought the most Zentalis Pharmaceuticals Llc stock with a total value of $215,723,200.00.
The most recent insider trade for Zentalis Pharmaceuticals Llc was on May 9, 2024.
The single biggest insider buy for Zentalis Pharmaceuticals Llc was from Matrix Capital Management Comp with a total value of $107,861,600.00 on June 20, 2023.
The single biggest insider sell for Zentalis Pharmaceuticals Llc was from Global Investors Lp Viking with a total value of $25,250,000.00 on Dec. 1, 2020.